Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFOPERAZONE\SULBACTAM for Anti-infective therapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 106 adverse event reports in the FDA FAERS database where CEFOPERAZONE\SULBACTAM was used for Anti-infective therapy.

Most Reported Side Effects for CEFOPERAZONE\SULBACTAM

Side Effect Reports % Deaths Hosp.
Off label use 155 19.5% 20 65
Drug ineffective 88 11.0% 42 38
Coagulopathy 62 7.8% 4 40
Platelet count decreased 59 7.4% 3 23
Hepatic function abnormal 57 7.2% 4 10
Drug-induced liver injury 39 4.9% 3 14
Condition aggravated 38 4.8% 7 20
Pyrexia 34 4.3% 5 21
Diarrhoea 32 4.0% 3 19
Pruritus 31 3.9% 0 12
Rash 27 3.4% 2 10
Product use in unapproved indication 25 3.1% 2 9
Dyspnoea 24 3.0% 1 18
Pathogen resistance 24 3.0% 10 15
Haemoglobin decreased 23 2.9% 1 11

Other Indications for CEFOPERAZONE\SULBACTAM

Pneumonia (153) Infection (87) Antibiotic therapy (52) Product used for unknown indication (40) Lung infection (37) Covid-19 (24) Pyrexia (19) Klebsiella infection (17) Sepsis (16) Infection prophylaxis (13)

Other Drugs Used for Anti-infective therapy

CILASTATIN\IMIPENEM (556) LINEZOLID (305) PIPERACILLIN\TAZOBACTAM (300) MEROPENEM (241) TIGECYCLINE (216) MOXIFLOXACIN (197) VANCOMYCIN (138) AZITHROMYCIN (133) VORICONAZOLE (114) ERTAPENEM (71)

Related Pages

CEFOPERAZONE\SULBACTAM Full Profile All Anti-infective therapy Drugs CEFOPERAZONE\SULBACTAM Demographics CEFOPERAZONE\SULBACTAM Timeline